Benzaprinoxide

This classification denotes an antidepressant agent with the molecular formula C20H20ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8J11WBM781, chemically known as 1-propanamine, 3-(1-chloro-5h-dibenzo(a,d)cyclohepten-5-ylidene)-n,n-dimethyl-, n-oxide but generally known as benzaprinoxide, which bears US NIH Compound Identifier 6436093. European Medicines Agency schedules Benzaprinoxide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05739MIG. The term BENZAPRINOXIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). BENZAPRINOXIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benzaprinoxide under HS 29299000 and SITC 51489. As of Q4 2014, BENZAPRINOXIDE remains the US FDA Preferred Term for this commodity. Benzaprinoxide bears US NLM identifiers UMLS ID C2607957 and NCI Concept Code C79853. SMILES: Clc1c2c(/C(=C\CC[N](O)(C)C)c3c(C=C2)cccc3)ccc1.